Prosecution Insights
Last updated: July 17, 2026
Application No. 17/728,601

COMPOSITIONS OF NITRATES AND METHODS OF USE THEREOF

Final Rejection §101§102§103
Filed
Apr 25, 2022
Priority
Feb 26, 2007 — SE 0700520-0 +11 more
Examiner
BARHAM, BETHANY P
Art Unit
1611
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Heartbeet Ltd.
OA Round
7 (Final)
51%
Grant Probability
Moderate
8-9
OA Rounds
0m
Est. Remaining
83%
With Interview

Examiner Intelligence

Grants 51% of resolved cases
51%
Career Allowance Rate
264 granted / 515 resolved
-8.7% vs TC avg
Strong +32% interview lift
Without
With
+31.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
16 currently pending
Career history
531
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
79.6%
+39.6% vs TC avg
§102
8.1%
-31.9% vs TC avg
§112
4.1%
-35.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 515 resolved cases

Office Action

§101 §102 §103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Summary The response and amendments filed on 12/22/2025 is acknowledged. Claims 1-2 and 4-32 are pending, claims 6-8, 13-15, 22 and 25-26 remain withdrawn and while claims 1-2, 4-5, 9-12, 16-21, 23-24 and 27-32 are examined herein and rejected. Modified REJECTIONS Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-2, 4-5, 9-12, 16-19, 21, 23-24 and 27-32 are rejected under 35 U.S.C. 101 because the claimed invention is directed to a natural phenomenon without significantly more. The claim(s) recite(s) ‘a method of reducing blood pressure in a human comprising orally administering to the human a single composition comprising NO2- and an acid; wherein the acid is one or more of citric acid, ascorbic acid, and acetic acid’ which reads on eating a beet salad or eating cabbage or sauerkraut. This judicial exception is not integrated into a practical application because the act of ingesting a single composition (i.e. a salad or fruit smoothie) which necessarily results in lowered blood pressure does not add a meaningful limitation to the method. The claim(s) do not include additional elements that are sufficient to amount to significantly more than the judicial exception because nitrites and acids are found naturally in food products and the results of a diet rich in fruits and vegetables is necessarily lower blood pressure. The instant claims do not contain anything significantly more than what is found in natural food products which are ingested by humans via a normal healthy diet which results in lower cardiovascular risk and lowered blood pressure. For example, Smiechowska teaches that beets, carrots, cabbage, sour cabbage, black currants, etc. all contain various amounts of NaNO2 and also vitamin C (i.e. ascorbic acid) (Tables 2-5). According to Appel et al the diet rich in vegetables and fruit is known to treat and lower blood pressure both systolic and diastolic (abstract, diets pg 1118, Table 1, 1121-1122). Therefore the instant claims read on nothing more than eating a beet salad or sauerkraut or drinking black currant juice the end result of lower blood pressure is a natural phenomenon of eating a DASH type diet or a combination diet with > amounts of fruit and vegetables. Further Houston et al teaches that juice powder concentrates are known to decrease systemic blood pressure (abstract). Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-2, 3-4, 9-12, 16-21, 23-24 and 27-32 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Houston et al as evidenced by Smiechowska and Toldam-Anderson. Houston et al teaches the oral intake of a capsule to effectively treat high blood pressure and lower cardiovascular risk (abstract, method). Capsules contained a phytonutrient mix of fruits, vegetables, and berries “including: acerola cherry, apple, beet, bilberry, blackberry, black currant, blueberry, broccoli, cabbage, carrot, cranberry, Concord grape, elderberry, kale, orange, papaya, parsley, peach, pineapple, raspberry, red currant, spinach and tomato.” As evidenced by Smiechowska many of these beets, carrots, cabbage, sour cabbage, black currants, etc. all contain various amounts of NaNO2 and also vitamin C (i.e. ascorbic acid) (Tables 2-5), whereas Toldam-Anderson shows that black currants additionally contain malic acid and citric acid. Houston shows that both systolic and diastolic blood pressure were lowered in Tables 1 and 3. Further it is noted that many of the above fruits and vegetables in the capsules are known to contain polyphenols since they are the same ones instant claimed. Claims 1-2, 3-4, 9-12, 16-21, 23-24 and 27-32 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Appel et al as evidenced by Smiechowska. Appel et al teach that blood pressure both systolic and diastolic is lowered by the eating of more than 3 servings of vegetables and more than 5 servings of fruits for a total of 8-10 servings combined a day (abstract, table 1 and 5, pg. 1122). According to Appel et al the blood pressure was reduced in those eating a strict DASH diet and even more so in those eating a combination diet that just included more than the 2.5 avg vegetable servings that a typical American diet has (pg. 1121-1122, Table 4 and Fig. 1). Appel teaches by increasing the intake of vegetables and fruit that blood pressure is lowered such that drug monotherapies are not needed (pg. 1123). According to Smiechowska numerous fruit and vegetables have both nitrite (NaNO2) and also acid in them not limited to but including apples, black currants, carrots, beets, cabbage, tomatos, greens, sour cabbage, etc all contain various amounts of NaNO2 and also vitamin C (i.e. ascorbic acid) (Tables 1-5). As such eating a diet rich in vegetables and fruit would necessarily include nitrite and acid with polyphenols and the method is anticipated by the eating of a salad or smoothie. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102 of this title, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-2, 4-5, 9-12, 16-21, 23-24 and 27-32 are rejected under 35 U.S.C. 103 as being unpatentable over by Houston et al as evidenced by Smiechowska and Toldam-Anderson et al and further in view of Gladwin et al. In the instance that the claims are not anticipated they are then obvious over the above cited references as the combination of various vegetables and fruits in a single meal would necessarily result in the intake of nitrite and acid which is known to decrease both systolic and diastolic blood pressure. Appel et al does not specifically link nitrite and acid to the ‘lowered blood pressure’ but just increased intake of fruits and vegetables which necessarily have nitrite and acid in them as affirmed by Smiechowska. Other acids other than vitamin C were not studied by Smiechowska. Further Gladwin confirms that increasing nitrite intake is known to reduce blood pressure when administered orally (title, abstract, claims) and claims state that sodium nitrite is a known salt to administer. As such it would have been obvious to one of ordinary skill at the time of filing that increasing the intake of fruits and vegetables rich in nitrite and acids and polyphenols are known to reduce blood pressure. The combination of a known method of reducing blood pressure with various naturally occurring fruits and vegetables concentrates in a capsule with the known method of reducing blood pressure with nitrite would necessarily yield lowered blood pressure since the fruits and vegetables of the concentrate capsules of Houston contain the same components of nitrite, acid such as ascorbic acid (i.e. Vitamin C) and polyphenol naturally. The combination of 2 known methods for the same purpose for a 3rd formulation or enriched composition which would necessarily treat blood pressure would be obvious to the skilled artisan at the time of filing. Response to Arguments Applicant's arguments with respect to claims 1-2, 4-5, 9-12, 16-21, 23-25 and 27-32 have been considered but are not persuasive in light of the above modified rejections necessitated by applicants’ amendments. Applicant argues that ‘administration of a single nutritional supplement composition comprising…a nitrite …an acid’ wherein the acid is now one of ascorbic acid, acetic acid or citric acid withdraws from possibility of reading on natural food items. Applicant argues that as supported by the spec the acidifying agents can include those that “reduce pH and include artificial compounds as well as natural juices…”. The examiner is not persuaded that the applicants amendments to the claims are directed to ‘synthetic’ or ‘artificial’ acids as argued especially since citrus fruits and vegetables contain things like citric acid and as well as the shown vitamin C which the ‘other’ common name for vitamin C is ascorbic acid (see Wikipedia cite for support). Applicants argument with respect to the phrase ‘nutritional supplement’ excluding natural fruits and vegetables is also not persuasive since clearly as shown in the prior art the natural products of fruits and vegetables contain the same instant claimed components and can also be ‘powdered’ or concentrated in juices. The definition provided by applicant for nutritional supplement does not support their argument with regards to natural products and as such the rejection is maintained. Further with respect to the prior art rejections (modified herein due to the amendment to the claims) a similar reason as above they are maintained since the prior art clearly envisages people eating vegetables and fruits as well as a capsule concentrate which contains a mixture of fruits, vegetables include beets, blackberry, black currants, etc. which contain as supported by Smiechowska various amounts of nitrite and acids including vitamin C (i.e. ascorbic acid) and Toldam Anderson shows that black currants also contain citric acid as well…wherein these compositions are known to treat and lower blood pressure. Applicant argues that the ‘capsule’ of Houston is not a single nutritional supplement as instant claimed. The examiner disagrees and argues that while applicant can be its own lexicographer applicant has not distinguished how the ‘nutritional supplement’ as claimed is novel over the capsule of Houston which contains the same components in powdered form the evidentiary nutritional references supplied are merely to show that these claimed acids and nitrite are found in the components that are in the capsule of Houston necessarily and a product is not separable from its physical characteristics (i.e. Vitamin C containing fruits and vegetables necessarily contain at least ascorbic acid while citrus fruits and others in Houston also contain citric acid). Eating the same fruits and vegetables produces the same results of lowering blood pressure as provided by the art and nothing in applicants claims seeks to modify the ‘structure’ of the composition to overcome the fact that this reads on eating a natural product especially since the majority of the claims contain no % or amounts of the nitrite and acid and further the nutritional tables provided by the examiner shows that these are the same and/or overlapping amounts found within the fruits and vegetables themselves and as such would be anticipated or obvious. Applicant bears the burden of distinguishing their invention over that of these natural products which are already known to treat and lower blood pressure when eaten either in their natural form or in the capsule of Houston. Cited As Interest From Wayback Machine 12/05/2005 Wikipedia page –“Vitamin C” wherein the structure is shown is the same as ascorbic acid and further ‘other names’ lists ascorbic acid which is further taught to be in citrus, sauerkraut, and other fruits such as berries and vegetables (pages 1-2). Further pages 3-4 tables and text support the known natural sources which includes beets, various fruits berries and citrus, and black currant etc.. Conclusions Applicant's amendment necessitated the modified ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action. Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to BETHANY BARHAM whose telephone number is (571)272-6175. The examiner can normally be reached on M-F 9:30AM-6pm. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BETHANY P BARHAM/ Supervisory Patent Examiner, Art Unit 1611
Read full office action

Prosecution Timeline

Show 13 earlier events
May 23, 2024
Final Rejection mailed — §101, §102, §103
Aug 23, 2024
Request for Continued Examination
Aug 27, 2024
Response after Non-Final Action
Jan 15, 2025
Non-Final Rejection mailed — §101, §102, §103
May 15, 2025
Response Filed
Jul 22, 2025
Non-Final Rejection mailed — §101, §102, §103
Dec 22, 2025
Response Filed
Apr 20, 2026
Final Rejection mailed — §101, §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12673021
USE OF CAVIAR EXTRACTS
3y 2m to grant Granted Jul 07, 2026
Patent 12673948
SULFOXIMINE-CONTAINING ATR INHIBITOR COMPOUND
2y 6m to grant Granted Jul 07, 2026
Patent 12653794
DEXTROMETHORPHAN TRANSDERMAL DELIVERY DEVICE
2y 8m to grant Granted Jun 16, 2026
Patent 12648979
COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND MORINGA PLANT COMPONENTS
4y 0m to grant Granted Jun 09, 2026
Patent 12648980
COMPOSITION FOR PREVENTING OR AMELIORATING BROMHIDROSIS COMPRISING SEED FERMENTATION PRODUCT OF PLANT BELONGING TO THE GENUS LOTUS
3y 3m to grant Granted Jun 09, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

8-9
Expected OA Rounds
51%
Grant Probability
83%
With Interview (+31.8%)
3y 10m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 515 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month